Pitcairn’s AngioDynamics ANGO Stock Holding History

Pitcairn’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,850	Closed	-$121K	–	515
2020 Q2	$121K	Sell	11,850 -1,897	-14%	-$19.6K	0.01%	485
2020 Q1	$143K	Buy	+13,747	New	+$173K	0.02%	412

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Pitcairn's ANGO Position: Q3 2020 in Review

Pitcairn sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 11,850 shares — an estimated $121K sold.

Pitcairn first reported a position in ANGO in Q1 2020 and held it in 2 quarters. The position peaked at $143K in Q1 2020. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

Pitcairn reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
Pitcairn sold 11,850 AngioDynamics shares in Q3 2020, an estimated $121K.
Pitcairn first reported a position in AngioDynamics in Q1 2020 and held it in 2 quarters.
Pitcairn's AngioDynamics position peaked at $143K in Q1 2020.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Pitcairn's 13F filing for Q3 2020, filed 3 Nov 2020.